Skip to main

Ryan Summers, MD

Ryan J. Summers, MD

Biography

Ryan J. Summers, MD is an instructor in the Department of Pediatrics at Emory University School of Medicine. A pediatric hematologist practicing at Children's Healthcare of Atlanta, Dr. Summers specializes in the treatment of childhood blood cancers. He is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University in Atlanta, Georgia.

Education

Dr. Summers earned his medical degree from Emory University School of Medicine where he also completed his residency in pediatrics and his fellowship in pediatric hematology/oncology.

Titles & Roles

  • Instructor, Department of Pediatrics
    Emory University School of Medicine

Research

Dr. Summers is a translational researcher in the laboratory of Dr. Douglas Graham. His research interests are focused on targeting the receptor tyrosine kinase MERTK in T-cell ALL and on the implementation of precision medicine-based approaches to pediatric cancer care through the Aflac Precision Medicine Program.

Publications

Title/Journal Authors Publication Date

How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children.

Blood

 RJ Summers, DT Teachey, SP Hunger 02/16/2024

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.

Blood

 BL Wood, M Devidas, RJ Summers, Z Chen, B Asselin, KR Rabin, PA Zweidler-McKay, NJ Winick, MJ Borowitz, WL Carroll, EA Raetz, ML Loh, SP Hunger, KP Dunsmore, DT Teachey, SS Winter 12/14/2023

High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma.

Pediatric blood & cancer

 RJ Summers, VM Monroig, NP DeGroote, ZE West, E Katafias, TP Miller 11/01/2023

Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.

Nature communications

 H Mumme, BE Thomas, SS Bhasin, U Krishnan, B Dwivedi, P Perumalla, D Sarkar, GB Ulukaya, HS Sabnis, SI Park, D DeRyckere, SS Raikar, M Pauly, RJ Summers, SM Castellino, DS Wechsler, CC Porter, DK Graham, M Bhasin 10/05/2023

Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.

Pharmaceutical research

 JM Kelvin, J Jain, A Thapa, M Qui, LA Birnbaum, SG Moore, H Zecca, RJ Summers, JM Switchenko, E Costanza, B Uricoli, X Wang, NT Jui, H Fu, Y Du, D DeRyckere, DK Graham, EC Dreaden 09/01/2023

Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.

Scientific reports

 SS Bhasin, BE Thomas, RJ Summers, D Sarkar, H Mumme, W Pilcher, M Emam, SS Raikar, SI Park, SM Castellino, DK Graham, MK Bhasin, D DeRyckere 08/02/2023

Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.

bioRxiv : the preprint server for biology

 JM Kelvin, J Jain, A Thapa, M Qui, LA Birnbaum, SG Moore, H Zecca, RJ Summers, E Costanza, B Uricoli, X Wang, NT Jui, H Fu, Y Du, D DeRyckere, DK Graham, EC Dreaden 03/15/2023

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.

Cancers

 RJ Summers, J Jain, E Vasileiadi, B Smith, ML Chimenti, TY Yeung, J Kelvin, X Wang, SV Frye, HS Earp, JW Tyner, EC Dreaden, D DeRyckere, DK Graham 12/13/2022

SOHO State of the Art Updates and Next Questions | Novel Approaches to Pediatric T-cell ALL and T-Lymphoblastic Lymphoma.

Clinical lymphoma, myeloma & leukemia

 RJ Summers, DT Teachey 10/01/2022

Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.

JCO precision oncology

 RJ Summers, SM Castellino, CC Porter, TJ MacDonald, GD Basu, S Szelinger, MK Bhasin, T Cash, AB Carter, RC Castellino, JR Fangusaro, SG Mitchell, MG Pauly, B Pencheva, DS Wechsler, DK Graham, KC Goldsmith 04/01/2022